Sernova Biotherapeutics (FRA:PSH0) EV-to-Revenue : (As of Jun. 24, 2025)

Sernova Biotherapeutics EV-to-Revenue Chart

Sernova Biotherapeutics Annual Data
	Trend	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23	Oct24
EV-to-Revenue		Get a 7-Day Free Trial					-	-	-	-	-

Sernova Biotherapeutics Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sernova Biotherapeutics's EV-to-Revenue

For the Biotechnology subindustry, Sernova Biotherapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's EV-to-Revenue falls into.

Sernova Biotherapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sernova Biotherapeutics's EV-to-Revenue for today is calculated as:

Sernova Biotherapeutics's current Enterprise Value is €36.03 Mil.
Sernova Biotherapeutics's Revenue for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics  (FRA:PSH0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sernova Biotherapeutics's PS Ratiofor today is calculated as:

Sernova Biotherapeutics's share price for today is €0.0915.
Sernova Biotherapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description